Navigate to
-
AMCP Nexus offers opportunity to nurture next generation of managed care leaders
Prime Article: Stories -
Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC tirzepatide (Zepbound)/Eli Lilly/SC T2DM Access the complete...
-
Live updates from AMCP Annual Meeting
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...
-
Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics
Prime Article: Events -
Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report